I could see it going both ways. If I was using several single vials with different COAs then I would try to adjust each vial to minimize variability. I have three kits of Tirz so I just keep my math simple and assume 30mg instead of values listed on COA.
Do you guys dose based on the vial or the COA?
- Thread starter blueandazure
- Start date
- Status
Varixdos
GLP-1 Apprentice
I tend to use the lowest quantity vial from the COA when there's multiple vials tested. Seems to work so far, for me.
It depends how big a difference between the COA and bottle. For example, Reta I received for Nexaph said 24 mgs but COA was around 30- I dosed according to COA for that. Other vendors with a COA that is 1 mg over, I will dose according to the bottle.
IshimaruKenta
GLP-1 Enthusiast
For new people, I highly recommend going based off a COA, then once they're used to it, they can go off the vial.
I started out dosing based on the vial label, mostly because it was simple and that’s how most protocols are written anyway.
Later on I switched to dosing based on the COA mg/ml, thinking it might be more precise, especially when you see small batch-to-batch differences. I ran it that way for a while.
In the end I went back to dosing off the vial label for everyday use. It’s just easier to keep things consistent, avoid constantly recalculating, and track what you’re doing over time. Practically speaking, I didn’t notice any meaningful difference in results between the two approaches
Just to clarify, I’m mainly talking about peptides like BPC-157, TB-500, and similar ones where dosing protocols already vary quite a bit. For things like GHK-cu or NAD+, where I’ve seen COAs with a huge variance , I’m personally more careful and conservative with dosing.
Not saying there’s a right or wrong way to do it. This is just what I settled on, and I don’t think it makes a big difference as long as you’re in a reasonable range.
Later on I switched to dosing based on the COA mg/ml, thinking it might be more precise, especially when you see small batch-to-batch differences. I ran it that way for a while.
In the end I went back to dosing off the vial label for everyday use. It’s just easier to keep things consistent, avoid constantly recalculating, and track what you’re doing over time. Practically speaking, I didn’t notice any meaningful difference in results between the two approaches
Just to clarify, I’m mainly talking about peptides like BPC-157, TB-500, and similar ones where dosing protocols already vary quite a bit. For things like GHK-cu or NAD+, where I’ve seen COAs with a huge variance , I’m personally more careful and conservative with dosing.
Not saying there’s a right or wrong way to do it. This is just what I settled on, and I don’t think it makes a big difference as long as you’re in a reasonable range.
Calm Logic
GLP-1 Specialist
If you are making labels anyway:
Peptide Reconstitution Calculator
Calculate peptide reconstitution with BAC water and create printable labels with QR and Data Matrix codes
peppinlepew.github.io
Peptide Reconstitution Calculator
Calculate peptide reconstitution with BAC water and create printable labels with QR and Data Matrix codes
peppinlepew.github.io
Zydeceltico
GLP-1爱好者
- Member Since
- Oct 10, 2025
- Posts
- 6
- Likes Received
- 0
I'm not entirely sure how micro-accurate dosing even needs to be even considering EL's protocol of 2.5, 5, 7.5, etc. given that we ALL accept this as the industry standard for (and here's the catch) ALL users who will range DRAMATICALLY in age, gender, height, weight, etc. - but there's a one-size-fits-all dosing schedule?v2boi said:I started out dosing based on the vial label, mostly because it was simple and that’s how most protocols are written anyway.
Later on I switched to dosing based on the COA mg/ml, thinking it might be more precise, especially when you see small batch-to-batch differences. I ran it that way for a while.
In the end I went back to dosing off the vial label for everyday use. It’s just easier to keep things consistent, avoid constantly recalculating, and track what you’re doing over time. Practically speaking, I didn’t notice any meaningful difference in results between the two approaches
Just to clarify, I’m mainly talking about peptides like BPC-157, TB-500, and similar ones where dosing protocols already vary quite a bit. For things like GHK-cu or NAD+, where I’ve seen COAs with a huge variance , I’m personally more careful and conservative with dosing.
Not saying there’s a right or wrong way to do it. This is just what I settled on, and I don’t think it makes a big difference as long as you’re in a reasonable range.
Really?
Makes me think that fractions of milligrams on a weekly basis really probably don't matter at all.
Close counts.
IshimaruKenta
GLP-1 Enthusiast
I'd say the biggest thing would be what mg vial they're using. If it's a lower 10mg vial, that's probably right at 10 or maybe even 11-12. That's not that big of a deal. But let's say they have a 30 or 60mg vial, that can have much higher overfill, and if they're just starting out, they may have more side effects. Of course everyone is different and everyone will do what they want, I just think it's a good idea for beginners to dose off a COA, then decide after a month or so if they want to keep doing it.Zydeceltico said:
Chopper
GLP-1 Apprentice
FWIW, I am only a few months in to this, coming from branded Mounjaro. So far, I have dosed based on the coa. If I were to feel as if it was underdosed or something, I would probably revert to the vial mg. I am still @ 5mg Tirz currently and buying T30. IME so far, the gray market stuff has "felt" stronger than the Lily stuff.
woundcarping
GLP-1 Enthusiast
Bingo, add in dosing errors at 30mg/ml and the variability grows another way.Zydeceltico said:
Percentage is percentage.IshimaruKenta said:
10mg containing 12mg is exactly the same as a 60mg containing 72mg, or a 120mg containing 144mg.
A 10mg containing 13mg is “worse” than a 60mg containing 70mg.
I check COA's but go by what is stated on the vial. No two vitals are the same. Not even big pharma can't do it. Everything is plus or minus 10%. No one has ever taken the exact amount they think they have.
littledragon25
New member
I dose based by the COA of my own testing.
YoYoFat
GLP-1 Specialist
Per USP and cGMP, brand name manufacturers aim keep to less than 5% variability for most drugs, 3% or less for others. They aim for 1-2% for meds that affect blood glucose or blood pressure.latviantower said:
YoYoFat
GLP-1 Specialist
Bad idea.CandyCap said:
YoYoFat
GLP-1 Specialist
EL’s dosing schedule has nothing to do with grey.Zydeceltico said:
I would have significant sides if I was off by as little as 1.5mg. I know, because I’ve experienced it.
Zydeceltico
GLP-1爱好者
- Member Since
- Oct 10, 2025
- Posts
- 6
- Likes Received
- 0
I understand. I should put in my signature "YMMdefV from mine as I appear to have a very robust metabolism."YoYoFat said:
I have a friend who is stacking T and S alongside me and he also has to watch dosage that I am not affected by at all.
We all do possess diverse and unique combinations of metabolic character apparently.
Rootus346
GLP-1 Apprentice
I use the average of the mass from the COA, the independent test, and any more independent tests. Usually a dozen vials or so. But I don’t stress about it, either.
- Status
